Management of DKA in critically ill patients requires rapid recognition, hemodynamic stabilization, and correction of metabolic derangements. Initial treatment includes aggressive fluid resuscitation with isotonic saline to restore perfusion, followed by insulin infusion to suppress ketogenesis and normalize glucose. Electrolyte monitoring, especially potassium, is crucial before and during insulin therapy. Bicarbonate therapy is reserved for severe acidosis (pH < 6.9). Frequent monitoring of blood glucose, ketones, electrolytes, and acid-base status is essential in the ICU setting. Early identification of precipitating factors such as infection or myocardial infarction ensures comprehensive management and improves patient outcomes.
Intensive Care Medicine University Hospital Center, France
Dr. Prof. Mathieu Jozwaik is a distinguished specialist in Intensive Care Medicine at the University Hospital Center, France. With extensive expertise in managing critically ill patients, he is recognized for his contributions to advanced intensive care practices and for bringing clinical excellence and innovation to critical care delivery in France.